Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Top FTSE 100 Index shares to watch: BT Group, Vodafone, Shell, GSK
03:00am, Friday, 30'th Jan 2026
The FTSE 100 Index continued its rally this week and was hovering near its all-time high as market participants reacted to the key earnings by some American companies and Lloyds Bank. It was trading
GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth
11:00am, Wednesday, 28'th Jan 2026
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why GSK (GSK) is a Strong Growth Stock
10:45am, Wednesday, 28'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why GSK (GSK) is a Strong Momentum Stock
10:50am, Tuesday, 27'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AstraZeneca the 'top pick' among European pharmas - broker
08:15am, Tuesday, 27'th Jan 2026
Analysts at Citi see AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) as 'the top pick' among European pharmaceutical firms'. The FTSE 100 drugmaker is forecast by...
GSK (NYSE:GSK) Stock Crosses Above 200 Day Moving Average – Time to Sell?
03:30am, Tuesday, 27'th Jan 2026
GSK PLC Sponsored ADR (NYSE: GSK - Get Free Report) shares crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $43.95 and trade
FINANCIAL CONSULATE, INC Buys 215 Shares of GSK PLC (GSK)
09:13am, Thursday, 22'nd Jan 2026
Summary FINANCIAL CONSULATE, INC raised its stake in GSK PLC (GSK) by 170.63%, purchasing 215 shares to own 341 shares valued at about $16,730 as of th
Prime Capital Investment Advisors, LLC Buys 19,509 Shares of GSK PLC (GSK)
09:10pm, Wednesday, 21'st Jan 2026
Summary Prime Capital Investment Advisors, LLC raised its stake in GSK PLC (GSK) by 182.69%, purchasing 19,509 shares to own 30,188 shares valued at ab
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of R
GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout
11:25am, Wednesday, 21'st Jan 2026
GSK agrees to buy RAPT Therapeutics for $2.2B, adding ozureprubart to its pipeline and strengthening its respiratory and immunology portfolio.
GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026
10:00am, Wednesday, 21'st Jan 2026
PHILADELPHIA--(BUSINESS WIRE)-- #DiseaseEducation--GSK awards $2M in COiMMUNITY Initiative grants to help close vaccination gaps, commits $3M for 2026.
BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now?
02:42pm, Tuesday, 20'th Jan 2026
Bristol Myers Squibb BMY and GSK PLC GSK are among the largest global biopharma companies with broad and diverse portfolios.
Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK
02:13pm, Tuesday, 20'th Jan 2026
NAARDEN, The Netherlands, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Forbion, a leading life sciences venture capital firm with deep roots in Europe, today announces that GSK (NYSE: GSK) has entered into a def
Wealth Management Associates, Inc. Buys 4,124 Shares of GSK PLC (GSK)
09:08am, Tuesday, 20'th Jan 2026
Summary Wealth Management Associates, Inc. initiated a new position in GSK PLC(GSK), purchasing 4,124 shares valued at approximately $202,260 as of its
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
09:00am, Tuesday, 20'th Jan 2026
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and lo
